Aspira Women's Health appoints Sandford as CEO, Palmieri as Executive Chair

Aspira Women's Health Inc.

Nicole Sandford appointed President and CEO effective March 1, 2022; base salary $500,000, one-year term.
Valerie Palmieri transitions to Executive Chair effective March 1; base salary $450,000, one-year term.
Celeste Fralick, Ph.D., appointed to Board effective Feb 23, 2022; will serve on Audit Committee.
Bylaws amended to require lead director selection if Board chair is not an independent director.

item 5.02 item 5.03 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Valerie B. Palmieri

Executive Chairperson

AWHL · Aspira Women's Health Inc.

Effective: 2022-03-01
Filed: February 28, 2022, 6:59 PM ET

On February 23, 2022, the board of directors (the “Board”) of Aspira Women’s Health Inc. (the “Company”) appointed Valerie B. Palmieri as its Executive Chairperson, effective as of March 1, 2022.

Appointed

Nicole Sandford

President and Chief Executive Officer

AWHL · Aspira Women's Health Inc.

Effective: 2022-03-01
Filed: February 28, 2022, 6:59 PM ET

On February 23, 2022, the Board appointed Nicole Sandford, a current director on the Board, as the Company’s President and Chief Executive Officer, effective as of March 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Valerie B. Palmieri was appointed as Executive Chairperson at Aspira Women's Health Inc..

Action: appointed
Role: Executive Chairperson

Exact text from the filing

On February 23, 2022, the board of directors (the “Board”) of Aspira Women’s Health Inc. (the “Company”) appointed Valerie B. Palmieri as its Executive Chairperson, effective as of March 1, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Nicole Sandford was appointed as President and Chief Executive Officer at Aspira Women's Health Inc..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

On February 23, 2022, the Board appointed Nicole Sandford, a current director on the Board, as the Company’s President and Chief Executive Officer, effective as of March 1, 2022.

View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0001387131-22-002576

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.